Cefacetrile
Clinical data | |
---|---|
Trade names | Celospor, Celtol, Cristacef |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intravenous, intramuscular, intramammary |
ATC code | J01DB10 (WHO) QJ51DB10 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 23 to 38% |
Biological half-life | 1.2 hours |
Excretion | Renal (72%) |
Identifiers | |
| |
CAS Number | 10206-21-0 |
PubChem (CID) | 91562 |
DrugBank | DB01414 |
ChemSpider | 82675 |
UNII | FDM21QQ344 |
KEGG | D07629 |
ChEMBL | CHEMBL2104099 |
ECHA InfoCard | 100.030.449 |
Chemical and physical data | |
Formula | C13H13N3O6S |
Molar mass | 339.325 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in gram-positive and gram-negative bacterial infections. It is a bacteriostatic antibiotic.[1][2] Cefacetrile is marketed under the trade names Celospor, Celtol, and Cristacef,[3] and as Vetimast for the treatment of mammary infections in lactating cows.[2]
Synthesis
It was made by reacting 7-ACA (7-aminocephalosporanic acid) with cyanoacetyl chloride in the presence of tributylamine.
References
- ↑ "Cefacetrile Summary Report" (PDF). European Medicines Agency, Committee for Veterinary Medicinal Products. 1998.
- 1 2 Haberfeld, H, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 3-85200-183-8.
- ↑ Horiuchi, N.; Oyakawa, Y.; Oka, R.; Fujiwara, T. (1980). "Clinical evaluation of cephacetrile (Celtol) for respiratory infections (author's transl)". The Japanese journal of antibiotics. 33 (10): 1145–1155. PMID 7206219.
This article is issued from Wikipedia - version of the 8/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.